FP7-PEOPLE-2011-ITN
FP7-PEOPLE-2011-ITN
Programme: FP7
93 projects · €348,385,577 total EU contribution (project-level) · 582 participating organizations · 33 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€348,385,577
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (101)
- UK (79)
- Spain (54)
- France (51)
- Italy (49)
- Netherlands (38)
- SE (26)
- AT (24)
- BE (23)
- CH (21)
- DK (12)
- PT (12)
- FI (11)
- CZ (9)
- HU (8)
- IL (8)
- EL (7)
- IE (6)
- NO (6)
- RS (6)
- PL (5)
- IS (4)
- RO (4)
- SI (4)
- TR (4)
- SK (2)
- CL (1)
- EG (1)
- HR (1)
- IN (1)
- LT (1)
- PS (1)
- UY (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS30 projects · FR
- UCPH11 projects · DK
- UOXF11 projects · UK
- CSIC9 projects · ES
- KU Leuven9 projects · BE
- UNIGE9 projects · CH
- MPG8 projects · DE
- STICHTING RADBOUD UNIVERSITEIT8 projects · NL
- CNR6 projects · IT
- ETH Zürich6 projects · CH
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE6 projects · UK
- RIJKSUNIVERSITEIT GRONINGEN6 projects · NL
Projects
Page 3 of 10
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Action research: Improving understanding and methodologies in early development ACT · 289404 | FP7 | €3,026,278 | €3,026,278 | Details |
The Urban Sound Planner SONORUS · 290110 | FP7 | €3,795,039 | €3,795,039 | Details |
Neural Engineering Transformative Technologies NETT · 289146 | FP7 | €5,329,091 | €5,329,091 | Details |
Translational Training network on the Cellular and Molecular Bases of Heart Homeostasis and Repair CARDIONET · 289600 | FP7 | €4,501,783 | €4,501,783 | Details |
Proton Ionization Molecular Mass Spectrometry PIMMS · 287382 | FP7 | €4,134,042 | €4,134,042 | Details |
Transglutaminase in disease: a novel therapeutic target? TRANSPATH · 289964 | FP7 | €3,740,034 | €3,740,034 | Details |
INVISIBLES INVISIBLES · 289442 | FP7 | €3,823,903 | €3,823,903 | Details |
LAsers for Applications at Accelerators: A Marie Curie Initial Training NETwork LA3-NET · 289191 | FP7 | €4,581,069 | €4,581,069 | Details |
ADenoViruses as novel clinical treatments ADVANCE · 290002 | FP7 | €3,861,450 | €3,861,450 | Details |
European Training Network for Excellence in Molecular Imaging in Diabetes BETATRAIN · 289932 | FP7 | €3,981,670 | €3,981,670 | Details |